Polymorphic variants INSIG2 rs6726538, HLA‐DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women. (14th February 2021)

• Record Type: Journal Article
• Authors: Hasan, Md. Emtiaz; Matin, Maliha; Haque, Md. Enamul; Aziz, Md. Abdul; Millat, Md. Shalahuddin; Uddin, Mohammad Sarowar; Moghal, Md. Mizanur Rahman; Islam, Mohammad Safiqul
• Is Part Of: Cancer medicine. Volume 10:Number 5(2021)
• Page Start: 1829
• Page End: 1838
• Publication Date: 2021-02-14
• Subjects: cervical cancer -- GCNT1P5 -- HLA‐DQB1 -- HLA‐DRB1 -- INSIG2 -- T‐ARMS‐PCR; 616.994005
• DOI: 10.1002/cam4.3782
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: Objective: Cervical cancer is a gynecological health problem, affecting nearly 500, 000 women each year worldwide. Genome‐wide association studies have revealed multiple susceptible genes and their polymorphisms for cervical carcinoma risk. We have carried out this case‐control study to investigate the association of INSIG2 rs6726538 (A; T), HLA ‐ DRB1 rs9272143 (T; C), and GCNT1P5 rs7780883 (G; A) with cervical cancer. Methods: The present study recruited 234 cervical cancer patients as cases and 212 healthy females as controls. We have applied the tetra‐primer amplification refractory mutation system polymerase chain reaction (T‐ARMS‐PCR) method for genotyping. Results: The SNP rs6726538 was significantly associated with increased risk of cervical cancer in all genetic models (AT vs. AA: OR = 3.30, 95% CI = 2.19–4.97, p < 0.0001; TT vs. AA: OR = 8.72, 95% CI = 3.87–19.7, p < 0.0001; AT+TT vs. AA: OR = 3.87, 95% CI = 2.61–5.73, p < 0.0001; T vs. A: OR = 2.97, 95% CI = 2.20–4.01, p < 0.0001) except the recessive model which showed a significantly reduced risk (TT vs. AA+AT: OR = 0.20, 95% CI = 0.09–0.44, p = 0.0001). rs9272143 showed significantly reduced risk for the additive model 1, dominant model, and allelic model (TC vs. TT: OR = 0.46, 95% CI = 0.31–0.70, p = 0.0004; TC+CC vs. TT: OR = 0.47 95% CI = 0.32–0.70, p = 0.0002; C vs. T: OR = 0.56, 95% CI = 0.40–0.78, p = 0.0006, respectively). The third variant, rs7780883, was significantly associated with increased risk in additive model 2, dominant, and allelic models (AA vs. GG: OR = 5.08, 95% CI = 2.45–10.5, p < 0.0001; GA+AA vs. GG: OR = 1.54, 95% CI = 1.06–2.24, p = 0.0237; A vs. G: OR = 1.88, 95% CI = 1.34–2.52, p < 0.0001, consecutively), whereas recessive model reduced the risk of cervical cancer (AA vs. GG+GA: OR = 0.20, 95% CI = 0.09–0.41, p < 0.0001). Other models of these SNPs were not associated with cervical cancer. All significant associations for three SNPs withstand after Bonferroni correction except the additive model 2 of rs7780883. Conclusion: Our study concludes that INSIG2 rs6726538, HLA ‐ DRB1 rs9272143, and GCNT1P5 rs7780883 polymorphisms may contribute to the development of cervical cancer in the Bangladeshi population. Abstract : Cervical cancer (CC) is a gynecological health problem, affecting nearly 500, 000 women each year worldwide. The present study recruited 234 cervical cancer patients as cases and 212 healthy females as controls. Our study concludes that rs6726538, rs9272143, and rs7780883 polymorphisms may contribute to the development of CC in the Bangladeshi population.